PHENOTYPIC AND GENOTYPIC CHARACTERISTICS OF PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS TYPE 3 IN PEDIATRIC POPULATION IN PAKISTAN

Main Article Content

Muhammad Ali
Huma Arshad Cheema
Muhammad Arshad Alvi
Nadia Waheed
Imran .
Muhammad Nadeem Anjum

Abstract

OBJECTIVE: To determine the phenotypic and genotypic characteristics of progressive familial intrahepatic cholestasis (PFIC) type 3 in Pakistani children in a hospital setting.


METHODS: This cross-sectional observational study was conducted at department of Pediatrics Gastroenterology & Hepatology, The Children’s Hospital Lahore, Pakistan from October 2020 to March 2021. Patients of either sex under 16 years of age presenting with jaundice, pruritus, neonatal cholestasis or with chronic liver and gamma glutamyl transferase >100 IU/ml were included in the study after taking informed consent by parents. For Molecular genetics 2ml blood in EDTA was sent to an international laboratory free of cost on research basis. Reports were assessed and levels were noted and genetic coding was also recorded. Data was entered and analyzed in SPSS version 22. Molecular data was interpreted with the help of clinical geneticist.


RESULTS: Out of 34 children, 14 (41.2%) were males and 20 (58.8%) were females. Mean age of children was 6.71±3.10 years. Consanguinity was noted in 32 (94.1%) parents having positive family history in 24 (70.6%) cases. The most common mutation was c. 1783C>T p.(Arg595*),  noted in 12 (35.3%) cases, followed by c. 2861G>T p.(Gly954 ASP) [8 (23.5%) cases], c. 153G>A p.(Trp51) [3 (8.8%) cases], c. 1714 C>T p.(Gln572*) c. 1906C>T p. (Gln636), c. 3220G>A p.(Gly1074Arg, c. 3433del p. (val1145Leufsx7)  in 2 (5.9%) cases each, c. 3859 C>T p.(1287Argext*) c. 88-91del p.(Lys30gly fsx7) and c. 1429c>T p. (Gln477) in one (2.9%) case each.


CONCLUSION: Children with PFIC type 3 have variable phenotypic and genotypic presentation.

Article Details

How to Cite
Ali, M., H. Cheema, M. A. Alvi, N. Waheed, I. ., and M. Anjum. “PHENOTYPIC AND GENOTYPIC CHARACTERISTICS OF PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS TYPE 3 IN PEDIATRIC POPULATION IN PAKISTAN”. KHYBER MEDICAL UNIVERSITY JOURNAL, Vol. 14, no. 1, Mar. 2022, doi:10.35845/kmuj.2022.21935.
Section
Original Articles

References

1. Jacquemin E. Progressive familial intrahepatic cholestasis. Clin Res Hepatol Gastroenterol 2012;36 Suppl 1:S26-35. https://doi.org/10.1016/S2210-7401(12)70018-9. PMID: 23141890.
2. Sticova E, Jirsa M. ABCB4 disease: Many faces of one gene deficiency. Ann Hepatol 2020;19(2):126-33. https://doi.org/10.1016/j.aohep.2019.09.010.
3.Davit-Spraul A, Gonzales E, Baussan C, Jacquemin E. Progressive familial intrahepatic cholestasis. Orphanet J Rare Dis 2009;4:1. https://doi.org/10.1186/1750-1172-4-1.
4. Aamann L, Ørntoft N, Vogel I, Grønbaek H, Becher N, Vilstrup H, et al. Unexplained cholestasis in adults and adolescents: diagnostic benefit of genetic examination. Scand J Gastroenterol 2018;53(3):305-11. https://doi.org/10.1080/00365521.2017.1422800.
5. König J, Rost D, Cui Y, Keppler D. Characterization of the human multidrug resistance protein isoform MRP3 localized to the basolateral hepatocyte membrane. Hepatology 1999;29(4):1156-63. https://doi.org/10.1002/hep.510290404.
6. Andress EJ, Nicolaou M, McGeoghan F, Linton KJ. ABCB4 missense mutations D243A, K435T, G535D, I490T, R545C, and S978P significantly impair the lipid floppase and likely predispose to secondary pathologies in the human population. Cell Mol Life Sci 2017;74(13):2513-2524. https://doi.org/10.1007/s00018-017-2472-6.
7. Agarwal S, Lal BB, Rawat D, Rastogi A, Bharathy KG, Alam S. Progressive Familial Intrahepatic Cholestasis (PFIC) in Indian Children: Clinical Spectrum and Outcome. J Clin Exp Hepatol 2016;6(3):203-208. https://doi.org/10.1016/j.jceh.2016.05.003.
8. Van Mil SW, Houwen RH, Klomp LW. Genetics of familial intrahepatic cholestasis syndromes. J Med Genet 2005;42(6):449-63. https://doi.org/10.1136/jmg.2004.026187.
9. Rosmorduc O, Poupon R. Low phospholipid associated cholelithiasis: association with mutation in the MDR3/ABCB4 gene. Orphanet J Rare Dis 2007;2:29. https://doi.org/10.1186/1750-1172-2-29.
10. Davit-Spraul A, Gonzales E, Baussan C, Jacquemin E. The spectrum of liver diseases related to ABCB4 gene mutations: pathophysiology and clinical aspects. Semin Liver Dis 2010;30(2):134-46. https://doi.org/10.1055/s-0030-1253223.
11. Wendum D, Barbu V, Rosmorduc O, Arrivé L, Fléjou JF, Poupon R. Aspects of liver pathology in adult patients with MDR3/ABCB4 gene mutations. Virchows Arch 2012;460(3):291-8. https://doi.org/10.1007/s00428-012-1202-6.
12. Boga S, Jain D, Schilsky ML. Presentation of progressive familial intrahepatic cholestasis type 3 mimicking wilson disease: molecular genetic diagnosis and response to treatment. Pediatr Gastroenterol Hepatol Nutr 2015;18(3):202-8. https://doi.org/10.5223/pghn.2015.18.3.202.
13. Davit-Spraul A, Gonzales E, Baussan C, Jacquemin E. Progressive familial intrahepatic cholestasis. Orphanet J Rare Dis 2009;4:1. https://doi.org/10.1186/1750-1172-4-1.
14. Jones-Hughes T, Campbell J, Crathorne L. Epidemiology and burden of progressive familial intrahepatic cholestasis: a systematic review. Orphanet J Rare Dis 2021;16:255.
https://doi.org/10.1186/s13023-021-01884-4.
15. Kang HJ, Hong SA, Oh SH, Kim KM, Yoo HW, Kim GH, et al. Progressive familial intrahepatic cholestasis in Korea: a clinicopathological study of five patients. J Pathol Transl Med 2019;53(4):253-60. https://doi.org/10.4132/jptm.2019.05.03.
16. Gaur K, Sakhuja P. Progressive familial intrahepatic cholestasis: A comprehensive review of a challenging liver disease. Indian J Pathol Microbiol 2017;60(1):2-7. https://doi.org/10.4103/0377-4929.200040.
17. Jacquemin E. Progressive familial intrahepatic cholestasis. Clin Res Hepatol Gastroenterol 2012;36 Suppl 1:S26-35. https://doi.org/10.1016/S2210-7401(12)70018-9.
18. Zhang BP, Huang ZH, Dong C. Biliary atresia combined with progressive familial intrahepatic cholestasis type 3: A case report and review of the literature. Medicine (Baltimore) 2019;98(19):e15593. https://doi.org/10.1097/MD.0000000000015593.
19. Siddiqi I, Tadi P. Progressive Familial Intrahepatic Cholestasis. [Updated 2021 Jul 25]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan
20. Amirneni S, Haep N, Gad MA, Soto-Gutierrez A, Squires JE, Florentino RM. Molecular overview of progressive familial intrahepatic cholestasis. World J Gastroenterol 2020;26(47):7470-84.https://doi.org/10.3748/wjg.v26.i47.7470.
21. Bull LN, Thompson RJ. Progressive familial intrahepatic cholestasis. Clin Liver Dis 2018;22(4):657-669. https://doi.org/10.1016/j.cld.2018.06.003.
22. Srivastava A. Progressive familial intrahepatic cholestasis. J Clin Exp Hepatol 2014;4(1):25-36. https://doi.org/10.1016/j.jceh.2013.10.005.
23. Baker A, Kerkar N, Todorova L, Kamath BM, Houwen RHJ. Systematic review of progressive familial intrahepatic cholestasis. Clin Res in Hepatol Gastroenterol 2019;43(1):20-36. https://doi.org/10.1016/j.clinre.2018.07.010.
24. Bosma PJ, Wits M, Oude-Elferink RP. Gene Therapy for Progressive Familial Intrahepatic Cholestasis: Current Progress and Future Prospects. Int J Mol Sci 2020;22(1):273. https//doi.org/10.3390/ijms22010273